We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $4.25B
1-Year Est. Return 141.71%
This Fund
S&P 500
This Quarter Est. Return
+50.94%
1 Year Est. Return
+141.71%
3 Year Est. Return
+486.97%
5 Year Est. Return
+675.33%
10 Year Est. Return
+5,134.3%
AUM
$4.25B
AUM Growth
+$1.09B
Cap. Flow
-$109M
Cap. Flow %
-2.57%
Top 10 Hldgs %
17.4%
Holding
276
New
28
Increased
80
Reduced
84
Closed
39

Top Buys

Rank Stock Value
1
LGN
Legence Corp
LGN
+$53.3M
2
SXT icon
Sensient Technologies
SXT
+$43.9M
3
IDCC icon
InterDigital
IDCC
+$35.5M
4
ACLS icon
Axcelis
ACLS
+$34.7M
5
TEX icon
Terex
TEX
+$34.1M

Sector Composition

Rank Sector Weight
1 Technology 27.23%
2 Industrials 24.1%
3 Healthcare 21.93%
4 Financials 9.1%
5 Consumer Discretionary 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TREE icon
101
LendingTree
TREE
$393M
$14.8M 0.35%
334,702
-4,967
-1% -$201K
WSBC icon
102
WesBanco
WSBC
$3.96B
$14.8M 0.35%
379,586
+378,721
+43,783% +$13.3M
AVAH icon
103
Aveanna Healthcare
AVAH
$2.98B
$14.1M 0.33%
1,642,406
-48,051
-3% -$339K
TRIN icon
104
Trinity Capital Inc
TRIN
$1.74B
$13.3M 0.31%
744,877
-21,313
-3% -$352K
WHK
105
WhiteHawk Minerals Corp
WHK
$670M
$11.6M 0.27%
+417,311
New +$11.3M
NVDA icon
106
NVIDIA
NVDA
$5.52T
$11.4M 0.27%
57,148
+5,227
+10% +$1.07M
AVEX
107
AEVEX Corp
AVEX
$922M
$11.3M 0.26%
+538,568
New +$14M
CRVS icon
108
Corvus Pharmaceuticals
CRVS
$1.23B
$10.2M 0.24%
685,683
-533
-0.1% -$7.4K
DAVE icon
109
Dave Inc
DAVE
$4.99B
$10.1M 0.24%
+26,993
New +$7.02M
VRDN icon
110
Viridian Therapeutics
VRDN
$2.6B
$9.87M 0.23%
+537,328
New +$8.66M
DFTX
111
Definium Therapeutics
DFTX
$5.11B
$8.41M 0.2%
+178,751
New +$4.42M
AMBA icon
112
Ambarella
AMBA
$2.78B
$8.28M 0.19%
+96,501
New +$6.64M
FLOC
113
Flowco Holdings
FLOC
$943M
$8.15M 0.19%
382,062
-4,873
-1% -$116K
WVE icon
114
Wave Life Sciences
WVE
$926M
$7.11M 0.17%
1,223,965
-37,218
-3% -$247K
MTUS icon
115
Metallus
MTUS
$794M
$6.85M 0.16%
366,351
-9,783
-3% -$184K
HAWK
116
HawkEye 360 Inc
HAWK
$1.7B
$6.56M 0.15%
+324,464
New +$8.96M
GOOGL icon
117
Alphabet (Google) Class A
GOOGL
$4.19T
$6.3M 0.15%
17,642
+1,622
+10% +$584K
BRCB
118
Black Rock Coffee Bar Inc
BRCB
$209M
$6.15M 0.14%
742,337
-7,289
-1% -$72.6K
AAPL icon
119
Apple
AAPL
$4.79T
$5.88M 0.14%
20,310
+691
+4% +$198K
CRDO icon
120
Credo Technology Group
CRDO
$30.9B
$5.27M 0.12%
19,362
-479,212
-96% -$94.7M
MSFT icon
121
Microsoft
MSFT
$3.79T
$4.81M 0.11%
12,893
-355
-3% -$144K
HTFL
122
Heartflow Inc
HTFL
$4.32B
$4.52M 0.11%
154,196
-67,106
-30% -$2.02M
AVGO icon
123
Broadcom
AVGO
$1.7T
$4.18M 0.1%
11,077
+239
+2% +$95.8K
EROC
124
ERock Inc
EROC
$564M
$4.07M 0.1%
+280,734
New +$4.47M
MTZ icon
125
MasTec
MTZ
$18.7B
$3.32M 0.08%
7,983
-544
-6% -$208K

Similar funds

Emerald Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Emerald Advisers held 276 positions worth $4.25B, up 34% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Emerald Advisers's Q2 2026 filing shows 28 new, 80 increased, 84 reduced and 39 closed positions. Its largest new stake was Legence Corp: 653,788 shares worth $55.7M. The largest sale was Bloom Energy, an estimated $137M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

  • Emerald Advisers's largest Q2 2026 buy was Legence Corp: 653,788 shares worth $55.7M.
  • Emerald Advisers added most to InterDigital in Q2 2026, an estimated $35.5M increase.
  • Emerald Advisers's biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $137M.
  • Emerald Advisers fully exited BridgeBio Pharma in Q2 2026, selling an estimated $38.3M.
  • Emerald Advisers's ten largest holdings make up 17% of its $4.25B portfolio in Q2 2026.
  • Emerald Advisers opened 28 new positions and closed 39 in Q2 2026.
  • Emerald Advisers's portfolio value rose 34% quarter-over-quarter to $4.25B.

Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.